Cencora, Inc. (COR) Earnings Call Analysis

NYSE · Healthcare · Medical Distribution

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Sencora (COR) Q3 2026: Specialty Platform Lifts Operating Income 17% Amid $1B Share Buyback
August 05, 2026
23
CENCORA (COR) Q1 2026: Operating Income Guidance Raised to 13.5% as MSO Platform Accelerates Scale
June 15, 2026
23
Sencora (COR) Q2 2026: Operating Income Up 6% as Specialty Platform Drives Margin Resilience
May 06, 2026
23
Sincora (COR) Q4 2025: Specialty-Driven 25% U.S. Operating Income Surge Reframes Long-Term Growth Path
November 05, 2025
24
Sancora (COR) Q3 2025: U.S. Healthcare Operating Income Jumps 29% as Specialty Drives Outperformance
August 06, 2025
24
CENCORA (COR) Q2 2025: U.S. Healthcare Operating Income Jumps 23% as Specialty Drives Margin Upside
June 30, 2025

Browse all companies